BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
XETRA:BNN
Price:
2.8 EUR
0.72%
Market Closed
Updated:
May 2, 2024
P/S
Price to Sales
Price to Sales
1.1
Current
2.8
Median
1.4
Industry
Lower
than median
Lower
than industry value
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
P/S
=1.1
Market Cap
/
61.2m
Revenue
55.2m
All Countries
| Market Cap | P/S | ||||
|---|---|---|---|---|---|
| DE |
|
BRAIN Biotech AG
XETRA:BNN
|
61.2m EUR | 1.1 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
12.1T JPY | 4.9 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
76.7B USD | 3.3 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
64.3B USD | 4.2 | |
| CH |
|
Sika AG
SIX:SIKA
|
42.2B CHF | 3.8 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
36.4B CHF | 5.3 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
279.8B CNY | 1.6 | |
| US |
|
Dupont De Nemours Inc
NYSE:DD
|
33.6B USD | 2.8 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.8T INR | 7.8 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
30.5B USD | 1.7 | |
| CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
28.1B EUR | 2.6 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/S
0.9
2-Years Forward
P/S
0.9
3-Years Forward
P/S
0.8
You don't have any saved screeners yet
